SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014683
Filing Date
2023-08-14
Accepted
2023-08-14 06:03:39
Documents
109
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20230630x10q.htm   iXBRL 10-Q 3189447
2 EX-10.6 jagx-20230630xex10d6.htm EX-10.6 52645
3 EX-10.7 jagx-20230630xex10d7.htm EX-10.7 32692
4 EX-31.1 jagx-20230630xex31d1.htm EX-31.1 11008
5 EX-31.2 jagx-20230630xex31d2.htm EX-31.2 11007
6 EX-32.1 jagx-20230630xex32d1.htm EX-32.1 6964
7 EX-32.2 jagx-20230630xex32d2.htm EX-32.2 6939
8 GRAPHIC jagx-20230630xex10d7001.jpg GRAPHIC 7168
  Complete submission text file 0001558370-23-014683.txt   13601751

Data Files

Seq Description Document Type Size
9 EX-101.SCH jagx-20230630.xsd EX-101.SCH 102513
10 EX-101.CAL jagx-20230630_cal.xml EX-101.CAL 70605
11 EX-101.DEF jagx-20230630_def.xml EX-101.DEF 500688
12 EX-101.LAB jagx-20230630_lab.xml EX-101.LAB 755445
13 EX-101.PRE jagx-20230630_pre.xml EX-101.PRE 671525
103 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20230630x10q_htm.xml XML 2393648
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 231165985
SIC: 2834 Pharmaceutical Preparations